Home › Calculator › CNVVY Dividend Calculator 2026
CNVVY DRIP Calculator & Dividend Yield 2026
2.25% YieldHealthcareConvaTec Group Plc · OTC
Price: $13.28 · Annual div: $0.2988/share · Frequency: semi-annual · Payout ratio: 88% · Ex-div: 2026-08-21
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CNVVY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
CNVVY Dividend History — Last 19 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-08-21Latest | 2026-10-15 | $0.0855 | 3.05% | $12.26 |
| 2026-04-17 | 2026-06-11 | $0.2134 | 4.12% | $11.76 |
| 2025-08-22 | 2025-10-16 | $0.0756 | 2.67% | $12.41 |
| 2025-04-22 | 2025-06-12 | $0.1958 | 2.89% | $13.81 |
| 2024-08-23 | 2024-10-21 | $0.0597 | 1.69% | $12.00 |
| 2024-04-25 | 2024-06-07 | $0.1433 | 1.33% | $14.77 |
| 2023-08-17 | 2023-10-13 | $0.0538 | 2.20% | $11.30 |
| 2023-04-10 | 2023-06-09 | $0.1440 | 1.73% | $11.27 |
| 2022-08-25 | 2022-10-21 | $0.0506 | 1.98% | $11.64 |
| 2022-03-31 | 2022-06-03 | $0.1262 | 3.16% | $9.73 |
| 2021-09-02 | 2021-10-28 | $0.0537 | 1.84% | $12.80 |
| 2021-04-05 | 2021-05-27 | $0.1276 | 1.70% | $10.67 |
| 2020-09-03 | 2020-10-29 | $0.0541 | — | — |
| 2020-04-02 | 2020-05-29 | $0.1306 | — | — |
| 2019-09-05 | 2019-10-31 | $0.0577 | — | — |
| 2019-04-04 | 2019-05-31 | $0.1385 | — | — |
| 2018-09-06 | 2018-10-26 | $0.0552 | — | — |
| 2018-04-05 | 2018-05-31 | $0.1469 | — | — |
| 2017-09-07 | 2017-11-03 | $0.0447 | — | — |
About ConvaTec Group Plc (CNVVY) — Dividend Analysis 2026
ConvaTec Group Plc operates as a global medical technology enterprise, specializing in the development, manufacturing, and distribution of a wide range of healthcare products. The company offers advanced wound care and skin protection solutions, tailored for the effective management of both acute and chronic wounds arising from diverse conditions such as diabetes, immobility, venous disease, traumatic injuries, burns, or complications following surgery. Furthermore, ConvaTec provides comprehensive ostomy care, including specialized devices, accessories, and support services for individuals living with a stoma, often necessitated by conditions like colorectal or bladder cancer, inflammatory bowel disease, obesity, among other medical reasons. Its product portfolio also extends to continence and critical care. This encompasses intermittent urinary catheters and solutions for managing bladder control issues linked to spinal cord injuries, multiple sclerosis, spina bifida, and various other urological disorders. Additionally, the firm supplies medical devices and products specifically designed for use in intensive care units (ICUs) and broader hospital settings. ConvaTec develops sophisticated systems for handling acute fecal incontinence, as well as for precise monitoring of urine production output and intra-abdominal pressure. A diverse array of disposable medical devices is also provided, featuring wound drainage systems, urine collection bags and catheters, equipment for airway management and oxygen/aerosol therapy, suction handles and tubing, gastroenterology tubes, and securement devices. The company is also a supplier of disposable infusion sets to manufacturers of insulin pumps for diabetic patients, and similar sets for pumps employed in continuous infusion treatments for other medical conditions. ConvaTec serves a broad spectrum of clients, including healthcare providers, patients, and other manufacturers. Its products reach both hospital and home healthcare markets, distributed through direct sales, as well as via distributors and wholesalers, targeting pharmacies, hospitals, and various acute and post-acute healthcare service providers. Established in 1978, the company's corporate headquarters are located in Reading, United Kingdom.
Similar dividend stocks to CNVVY
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CNVVY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CNVVY position with:
🌍 CNVVY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CNVVY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.25% | -0.55% | $225 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.91% | -0.89% | $191 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.80% | -1.00% | $180 / yr |
| 🇬🇧 UK ISA | 0% | 2.25% | -0.55% | $225 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.05% | -0.75% | $205 / yr |
| 🇨🇦 TFSA | 0% | 2.25% | -0.55% | $225 / yr |
| 🇨🇦 CA Taxable | 25% | 1.69% | -1.11% | $169 / yr |
| 🇦🇺 Super (pension) | 15% | 1.91% | -0.89% | $191 / yr |
| 🇦🇺 AU Taxable | 30% | 1.57% | -1.22% | $158 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.66% | -1.14% | $166 / yr |
| 🇫🇷 FR Taxable | 30% | 1.57% | -1.22% | $158 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CNVVY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.30/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CNVVY Dividend Payment Schedule
CNVVY pays quarterly — 4 times per year. Ex-div: 2026-08-21.
📊 CNVVY vs Healthcare Benchmarks
How CNVVY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CNVVY sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CNVVY Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare CNVVY with peers: CNVVY vs DSRLF · CNVVY vs FLMNF · CNVVY vs FLMNY
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CNVVY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
ConvaTec Group Plc (CNVVY) is currently trading at $13.28, 6% below its 52-week high. The current dividend yield is 2.25% based on an annual payout of $0.2988 per share.
CNVVY (ConvaTec Group Plc) — 2.25% Dividend Yield Analysis
ConvaTec Group Plc (CNVVY) is a healthcare stock currently trading at $13.28 with a dividend yield of 2.25%. It pays an annual dividend of $0.2988 per share. The payout ratio of 88% indicates investors should monitor dividend sustainability. Over the past 5 years, CNVVY has grown its dividend at a compound annual rate of 17.0%.
- High payout ratio (88%) — dividend cuts are possible if earnings decline.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest CNVVY News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
How investors use the CNVVY dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.